2024-07-22 Purchase |
2024-07-22 8:26 pm |
Artiva Biotherapeutics Inc. |
ARTV |
venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner |
416,666 |
$12 |
$4,999,992 |
2,398,324 (Direct) |
View |
2022-05-25 Sale |
2022-05-27 7:20 pm |
Elevation Oncology Inc. |
ELEV |
venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner |
702,737 |
$4.1236 |
$2,897,806 |
1,905,430 (Direct) |
View |
2022-05-13 Sale |
2022-05-17 5:12 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
131,650 |
$10.45 |
$1,375,564 |
2,155,930 (Direct) |
View |
2022-05-10 Sale |
2022-05-12 8:47 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
160,901 |
$10.39 |
$1,671,824 |
2,287,580 (Direct) |
View |
2022-05-05 Sale |
2022-05-09 6:58 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
86,677 |
$10.37 |
$898,921 |
2,448,481 (Direct) |
View |
2022-05-02 Sale |
2022-05-04 7:30 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
270,675 |
$10.38 |
$2,809,332 |
2,535,158 (Direct) |
View |
2022-04-27 Sale |
2022-04-29 5:50 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
190,026 |
$10.38 |
$1,972,579 |
2,805,833 (Direct) |
View |
2022-04-22 Sale |
2022-04-26 6:40 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
129,781 |
$10.39 |
$1,347,796 |
2,995,859 (Direct) |
View |
2022-04-19 Sale |
2022-04-21 8:54 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
547,734 |
$10.41 |
$5,700,491 |
3,125,640 (Direct) |
View |
2021-10-22 Sale |
2021-10-26 4:35 pm |
Metacrine Inc. |
MTCR |
venBio Global Strategic Fund L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
615,702 |
$1.5087 |
$928,902 |
2,443,421 (Direct) |
View |
2021-10-25 Purchase |
2021-10-25 7:40 pm |
Ventyx Biosciences Inc. |
VTYX |
venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner |
312,500 |
$16 |
$5,000,000 |
5,011,536 (Indirect Direct) |
View |
2021-06-29 Purchase |
2021-07-01 5:27 pm |
Elevation Oncology Inc. |
ELEV |
venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner |
625,000 |
$16 |
$10,000,000 |
2,608,167 (Direct) |
View |
2021-04-27 Purchase |
2021-04-29 6:44 pm |
IMPEL NEUROPHARMA INC |
IMPL |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
450,000 |
$15 |
$6,750,000 |
2,759,791 (Direct) |
View |
2020-09-18 Purchase |
2020-09-22 5:22 pm |
Metacrine Inc. |
MTCR |
Adelman Robert J Director 10% Owner |
230,000 |
$13 |
$2,990,000 |
3,059,123 (Direct) |
View |
2020-08-11 Purchase |
2020-08-12 9:00 pm |
Checkmate Pharmaceuticals Inc. |
CMPI |
venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
200,000 |
$15 |
$3,000,000 |
3,673,374 (Direct) |
View |